Synmosa Biopharma (4114) — Financial Flexibility Index
Synmosa Biopharma (4114) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of NT$245.19 Million (operating CF NT$185.72 Million minus capex NT$59.46 Million) represents 0% of total liabilities (NT$3.89 Billion). Also explore net asset growth rate of Synmosa Biopharma to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Synmosa Biopharma Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Synmosa Biopharma across 11 annual periods. Check 4114 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Synmosa Biopharma (2015–2025)
Year-by-year free cash flow to debt coverage for Synmosa Biopharma. For the full company profile including market capitalisation, see how much is Synmosa Biopharma worth.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | NT$692.71 Million | NT$411.57 Million | NT$3.89 Billion | ▼ -33.7% |
| 2024 | 0.27x | NT$1.05 Billion | NT$780.62 Million | NT$3.91 Billion | ▲ +24.8% |
| 2023 | 0.22x | NT$781.70 Million | NT$511.93 Million | NT$3.63 Billion | ▲ +29.2% |
| 2022 | 0.17x | NT$759.54 Million | NT$630.25 Million | NT$4.55 Billion | ▲ +31.0% |
| 2021 | 0.13x | NT$537.35 Million | NT$444.29 Million | NT$4.22 Billion | ▲ +37.7% |
| 2020 | 0.09x | NT$408.81 Million | NT$254.40 Million | NT$4.42 Billion | ▲ +161.4% |
| 2019 | 0.04x | NT$138.49 Million | NT$-44.88 Million | NT$3.92 Billion | ▼ -67.3% |
| 2018 | 0.11x | NT$330.43 Million | NT$16.00 Million | NT$3.06 Billion | ▲ +169.6% |
| 2017 | 0.04x | NT$141.74 Million | NT$-5.19 Million | NT$3.54 Billion | ▼ -85.2% |
| 2016 | 0.27x | NT$660.40 Million | NT$236.48 Million | NT$2.44 Billion | ▲ +8.9% |
| 2015 | 0.25x | NT$392.86 Million | NT$23.60 Million | NT$1.58 Billion | — |